Biomarkers Market Report by Product (Consumables, Services, Software), Type (Efficacy Biomarkers, Safety Biomarkers, Validation Biomarkers), Disease (Cancer, Cardiovascular Disorders, Neurological Disorders, Immunological Disorders, Renal Disorders, and Others), Application (Diagnostics, Drug Discovery and Development, Personalized Medicine, and Others), End User (Pharmaceutical and Biotechnology Companies, Diagnostic and Research Laboratories, Hospitals and Specialty Clinics, and Others), and Region 2024-2032

Biomarkers Market Report by Product (Consumables, Services, Software), Type (Efficacy Biomarkers, Safety Biomarkers, Validation Biomarkers), Disease (Cancer, Cardiovascular Disorders, Neurological Disorders, Immunological Disorders, Renal Disorders, and Others), Application (Diagnostics, Drug Discovery and Development, Personalized Medicine, and Others), End User (Pharmaceutical and Biotechnology Companies, Diagnostic and Research Laboratories, Hospitals and Specialty Clinics, and Others), and Region 2024-2032

Report Format: PDF+Excel | Report ID: SR112024A6320
Buy Now

1   Preface
2   Scope and Methodology

    2.1    Objectives of the Study
    2.2    Stakeholders
    2.3    Data Sources
        2.3.1    Primary Sources
        2.3.2    Secondary Sources
    2.4    Market Estimation
        2.4.1    Bottom-Up Approach
        2.4.2    Top-Down Approach
    2.5    Forecasting Methodology
3   Executive Summary
4   Introduction

    4.1    Overview
    4.2    Key Industry Trends
5   Global Biomarkers Market
    5.1    Market Overview
    5.2    Market Performance
    5.3    Impact of COVID-19
    5.4    Market Forecast
6   Market Breakup by Product
    6.1    Consumables
        6.1.1 Market Trends
        6.1.2 Market Forecast
    6.2    Services
        6.2.1 Market Trends
        6.2.2 Market Forecast
    6.3    Software
        6.3.1 Market Trends
        6.3.2 Market Forecast
7   Market Breakup by Type
    7.1    Efficacy Biomarkers
        7.1.1 Market Trends
        7.1.2 Market Forecast
    7.2    Safety Biomarkers
        7.2.1 Market Trends
        7.2.2 Market Forecast
    7.3    Validation Biomarkers
        7.3.1 Market Trends
        7.3.2 Market Forecast
8   Market Breakup by Disease
    8.1    Cancer
        8.1.1 Market Trends
        8.1.2 Market Forecast
    8.2    Cardiovascular Disorders
        8.2.1 Market Trends
        8.2.2 Market Forecast
    8.3    Neurological Disorders
        8.3.1 Market Trends
        8.3.2 Market Forecast
    8.4    Immunological Disorders
        8.4.1 Market Trends
        8.4.2 Market Forecast
    8.5    Renal Disorders
        8.5.1 Market Trends
        8.5.2 Market Forecast
    8.6    Others
        8.6.1 Market Trends
        8.6.2 Market Forecast
9   Market Breakup by Application 
    9.1    Diagnostics
        9.1.1 Market Trends
        9.1.2 Market Forecast
    9.2    Drug Discovery and Development
        9.2.1 Market Trends
        9.2.2 Market Forecast
    9.3    Personalized Medicine
        9.3.1 Market Trends
        9.3.2 Market Forecast
    9.4    Others
        9.4.1 Market Trends
        9.4.2 Market Forecast
10  Market Breakup by End User
    10.1    Pharmaceutical and Biotechnology Companies
        10.1.1 Market Trends
        10.1.2 Market Forecast
    10.2    Diagnostic and Research Laboratories
        10.2.1 Market Trends
        10.2.2 Market Forecast
    10.3    Hospitals and Specialty Clinics
        10.3.1 Market Trends
        10.3.2 Market Forecast
    10.4    Others
        10.4.1 Market Trends
        10.4.2 Market Forecast
11  Market Breakup by Region
    11.1    North America
        11.1.1 United States
           11.1.1.1 Market Trends
           11.1.1.2 Market Forecast
        11.1.2 Canada
           11.1.2.1 Market Trends
           11.1.2.2 Market Forecast
    11.2    Asia-Pacific
        11.2.1 China
           11.2.1.1 Market Trends
           11.2.1.2 Market Forecast
        11.2.2 Japan
           11.2.2.1 Market Trends
           11.2.2.2 Market Forecast
        11.2.3 India
           11.2.3.1 Market Trends
           11.2.3.2 Market Forecast
        11.2.4 South Korea
           11.2.4.1 Market Trends
           11.2.4.2 Market Forecast
        11.2.5 Australia
           11.2.5.1 Market Trends
           11.2.5.2 Market Forecast
        11.2.6 Indonesia
           11.2.6.1 Market Trends
           11.2.6.2 Market Forecast
        11.2.7 Others
           11.2.7.1 Market Trends
           11.2.7.2 Market Forecast
    11.3    Europe
        11.3.1 Germany
           11.3.1.1 Market Trends
           11.3.1.2 Market Forecast
        11.3.2 France
           11.3.2.1 Market Trends
           11.3.2.2 Market Forecast
        11.3.3 United Kingdom
           11.3.3.1 Market Trends
           11.3.3.2 Market Forecast
        11.3.4 Italy
           11.3.4.1 Market Trends
           11.3.4.2 Market Forecast
        11.3.5 Spain
           11.3.5.1 Market Trends
           11.3.5.2 Market Forecast
        11.3.6 Russia
           11.3.6.1 Market Trends
           11.3.6.2 Market Forecast
        11.3.7 Others
           11.3.7.1 Market Trends
           11.3.7.2 Market Forecast
    11.4    Latin America
        11.4.1 Brazil
           11.4.1.1 Market Trends
           11.4.1.2 Market Forecast
        11.4.2 Mexico
           11.4.2.1 Market Trends
           11.4.2.2 Market Forecast
        11.4.3 Others
           11.4.3.1 Market Trends
           11.4.3.2 Market Forecast
    11.5    Middle East and Africa
        11.5.1 Market Trends
        11.5.2 Market Breakup by Country
        11.5.3 Market Forecast
12  SWOT Analysis
    12.1    Overview
    12.2    Strengths
    12.3    Weaknesses
    12.4    Opportunities
    12.5    Threats
13  Value Chain Analysis
14  Porters Five Forces Analysis

    14.1    Overview
    14.2    Bargaining Power of Buyers
    14.3    Bargaining Power of Suppliers
    14.4    Degree of Competition
    14.5    Threat of New Entrants
    14.6    Threat of Substitutes
15  Price Analysis
16  Competitive Landscape

    16.1    Market Structure
    16.2    Key Players
    16.3    Profiles of Key Players
        16.3.1    Agilent Technologies Inc.
           16.3.1.1 Company Overview
           16.3.1.2 Product Portfolio
           16.3.1.3 Financials
           16.3.1.4 SWOT Analysis
        16.3.2    Bio-Rad Laboratories Inc.
           16.3.2.1 Company Overview
           16.3.2.2 Product Portfolio
           16.3.2.3 Financials
           16.3.2.4 SWOT Analysis
        16.3.3    Charles River Laboratories International Inc.
           16.3.3.1 Company Overview
           16.3.3.2 Product Portfolio
           16.3.3.3 Financials
           16.3.3.4 SWOT Analysis
        16.3.4    Epigenomics AG
           16.3.4.1 Company Overview
           16.3.4.2 Product Portfolio
           16.3.4.3 Financials
           16.3.4.4 SWOT Analysis
        16.3.5    Eurofins Scientific SE
           16.3.5.1 Company Overview
           16.3.5.2 Product Portfolio
           16.3.5.3 Financials
           16.3.5.4 SWOT Analysis
        16.3.6    Merck KGaA
           16.3.6.1 Company Overview
           16.3.6.2 Product Portfolio
           16.3.6.3 Financials
           16.3.6.4 SWOT Analysis
        16.3.7    Perkinelmer Inc.
           16.3.7.1 Company Overview
           16.3.7.2 Product Portfolio
           16.3.7.3 Financials
           16.3.7.4 SWOT Analysis
        16.3.8    Qiagen N.V
           16.3.8.1 Company Overview
           16.3.8.2 Product Portfolio
           16.3.8.3 Financials
           16.3.8.4 SWOT Analysis
        16.3.9    Quanterix Corporation
           16.3.9.1 Company Overview
           16.3.9.2 Product Portfolio
           16.3.9.3 Financials
        16.3.10    SphingoTec GmbH
           16.3.10.1 Company Overview
           16.3.10.2 Product Portfolio
        16.3.11    Thermo Fisher Scientific Inc.
           16.3.11.1 Company Overview
           16.3.11.2 Product Portfolio
           16.3.11.3 Financials
           16.3.11.4 SWOT Analysis

List of Figures

Figure 1: Global: Biomarkers Market: Major Drivers and Challenges
Figure 2: Global: Biomarkers Market: Sales Value (in Billion US$), 2018-2023
Figure 3: Global: Biomarkers Market Forecast: Sales Value (in Billion US$), 2024-2032
Figure 4: Global: Biomarkers Market: Breakup by Product (in %), 2023
Figure 5: Global: Biomarkers Market: Breakup by Type (in %), 2023
Figure 6: Global: Biomarkers Market: Breakup by Disease (in %), 2023
Figure 7: Global: Biomarkers Market: Breakup by Application (in %), 2023
Figure 8: Global: Biomarkers Market: Breakup by End User (in %), 2023
Figure 9: Global: Biomarkers Market: Breakup by Region (in %), 2023
Figure 10: Global: Biomarkers (Consumables) Market: Sales Value (in Million US$), 2018 & 2023
Figure 11: Global: Biomarkers (Consumables) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 12: Global: Biomarkers (Services) Market: Sales Value (in Million US$), 2018 & 2023
Figure 13: Global: Biomarkers (Services) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 14: Global: Biomarkers (Software) Market: Sales Value (in Million US$), 2018 & 2023
Figure 15: Global: Biomarkers (Software) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 16: Global: Biomarkers (Efficacy Biomarkers) Market: Sales Value (in Million US$), 2018 & 2023
Figure 17: Global: Biomarkers (Efficacy Biomarkers) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 18: Global: Biomarkers (Safety Biomarkers) Market: Sales Value (in Million US$), 2018 & 2023
Figure 19: Global: Biomarkers (Safety Biomarkers) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 20: Global: Biomarkers (Validation Biomarkers) Market: Sales Value (in Million US$), 2018 & 2023
Figure 21: Global: Biomarkers (Validation Biomarkers) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 22: Global: Biomarkers (Cancer) Market: Sales Value (in Million US$), 2018 & 2023
Figure 23: Global: Biomarkers (Cancer) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 24: Global: Biomarkers (Cardiovascular Disorders) Market: Sales Value (in Million US$), 2018 & 2023
Figure 25: Global: Biomarkers (Cardiovascular Disorders) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 26: Global: Biomarkers (Neurological Disorders) Market: Sales Value (in Million US$), 2018 & 2023
Figure 27: Global: Biomarkers (Neurological Disorders) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 28: Global: Biomarkers (Immunological Disorders) Market: Sales Value (in Million US$), 2018 & 2023
Figure 29: Global: Biomarkers (Immunological Disorders) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 30: Global: Biomarkers (Renal Disorders) Market: Sales Value (in Million US$), 2018 & 2023
Figure 31: Global: Biomarkers (Renal Disorders) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 32: Global: Biomarkers (Other Diseases) Market: Sales Value (in Million US$), 2018 & 2023
Figure 33: Global: Biomarkers (Other Diseases) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 34: Global: Biomarkers (Diagnostics) Market: Sales Value (in Million US$), 2018 & 2023
Figure 35: Global: Biomarkers (Diagnostics) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 36: Global: Biomarkers (Drug Discovery and Development) Market: Sales Value (in Million US$), 2018 & 2023
Figure 37: Global: Biomarkers (Drug Discovery and Development) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 38: Global: Biomarkers (Personalized Medicine) Market: Sales Value (in Million US$), 2018 & 2023
Figure 39: Global: Biomarkers (Personalized Medicine) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 40: Global: Biomarkers (Other Applications) Market: Sales Value (in Million US$), 2018 & 2023
Figure 41: Global: Biomarkers (Other Applications) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 42: Global: Biomarkers (Pharmaceutical and Biotechnology Companies) Market: Sales Value (in Million US$), 2018 & 2023
Figure 43: Global: Biomarkers (Pharmaceutical and Biotechnology Companies) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 44: Global: Biomarkers (Diagnostic and Research Laboratories) Market: Sales Value (in Million US$), 2018 & 2023
Figure 45: Global: Biomarkers (Diagnostic and Research Laboratories) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 46: Global: Biomarkers (Hospitals and Specialty Clinics) Market: Sales Value (in Million US$), 2018 & 2023
Figure 47: Global: Biomarkers (Hospitals and Specialty Clinics) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 48: Global: Biomarkers (Other End Users) Market: Sales Value (in Million US$), 2018 & 2023
Figure 49: Global: Biomarkers (Other End Users) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 50: North America: Biomarkers Market: Sales Value (in Million US$), 2018 & 2023
Figure 51: North America: Biomarkers Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 52: United States: Biomarkers Market: Sales Value (in Million US$), 2018 & 2023
Figure 53: United States: Biomarkers Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 54: Canada: Biomarkers Market: Sales Value (in Million US$), 2018 & 2023
Figure 55: Canada: Biomarkers Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 56: Asia-Pacific: Biomarkers Market: Sales Value (in Million US$), 2018 & 2023
Figure 57: Asia-Pacific: Biomarkers Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 58: China: Biomarkers Market: Sales Value (in Million US$), 2018 & 2023
Figure 59: China: Biomarkers Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 60: Japan: Biomarkers Market: Sales Value (in Million US$), 2018 & 2023
Figure 61: Japan: Biomarkers Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 62: India: Biomarkers Market: Sales Value (in Million US$), 2018 & 2023
Figure 63: India: Biomarkers Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 64: South Korea: Biomarkers Market: Sales Value (in Million US$), 2018 & 2023
Figure 65: South Korea: Biomarkers Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 66: Australia: Biomarkers Market: Sales Value (in Million US$), 2018 & 2023
Figure 67: Australia: Biomarkers Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 68: Indonesia: Biomarkers Market: Sales Value (in Million US$), 2018 & 2023
Figure 69: Indonesia: Biomarkers Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 70: Others: Biomarkers Market: Sales Value (in Million US$), 2018 & 2023
Figure 71: Others: Biomarkers Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 72: Europe: Biomarkers Market: Sales Value (in Million US$), 2018 & 2023
Figure 73: Europe: Biomarkers Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 74: Germany: Biomarkers Market: Sales Value (in Million US$), 2018 & 2023
Figure 75: Germany: Biomarkers Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 76: France: Biomarkers Market: Sales Value (in Million US$), 2018 & 2023
Figure 77: France: Biomarkers Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 78: United Kingdom: Biomarkers Market: Sales Value (in Million US$), 2018 & 2023
Figure 79: United Kingdom: Biomarkers Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 80: Italy: Biomarkers Market: Sales Value (in Million US$), 2018 & 2023
Figure 81: Italy: Biomarkers Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 82: Spain: Biomarkers Market: Sales Value (in Million US$), 2018 & 2023
Figure 83: Spain: Biomarkers Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 84: Russia: Biomarkers Market: Sales Value (in Million US$), 2018 & 2023
Figure 85: Russia: Biomarkers Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 86: Others: Biomarkers Market: Sales Value (in Million US$), 2018 & 2023
Figure 87: Others: Biomarkers Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 88: Latin America: Biomarkers Market: Sales Value (in Million US$), 2018 & 2023
Figure 89: Latin America: Biomarkers Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 90: Brazil: Biomarkers Market: Sales Value (in Million US$), 2018 & 2023
Figure 91: Brazil: Biomarkers Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 92: Mexico: Biomarkers Market: Sales Value (in Million US$), 2018 & 2023
Figure 93: Mexico: Biomarkers Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 94: Others: Biomarkers Market: Sales Value (in Million US$), 2018 & 2023
Figure 95: Others: Biomarkers Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 96: Middle East and Africa: Biomarkers Market: Sales Value (in Million US$), 2018 & 2023
Figure 97: Middle East and Africa: Biomarkers Market: Breakup by Country (in %), 2023
Figure 98: Middle East and Africa: Biomarkers Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 99: Global: Biomarkers Industry: SWOT Analysis
Figure 100: Global: Biomarkers Industry: Value Chain Analysis
Figure 101: Global: Biomarkers Industry: Porter's Five Forces Analysis

List of Tables

Table 1: Global: Biomarkers Market: Key Industry Highlights, 2023 and 2032
Table 2: Global: Biomarkers Market Forecast: Breakup by Product (in Million US$), 2024-2032
Table 3: Global: Biomarkers Market Forecast: Breakup by Type (in Million US$), 2024-2032
Table 4: Global: Biomarkers Market Forecast: Breakup by Disease (in Million US$), 2024-2032
Table 5: Global: Biomarkers Market Forecast: Breakup by Application (in Million US$), 2024-2032
Table 6: Global: Biomarkers Market Forecast: Breakup by End User (in Million US$), 2024-2032
Table 7: Global: Biomarkers Market Forecast: Breakup by Region (in Million US$), 2024-2032
Table 8: Global: Biomarkers Market: Competitive Structure
Table 9: Global: Biomarkers Market: Key Players

Biomarkers Market Report by Product (Consumables, Services, Software), Type (Efficacy Biomarkers, Safety Biomarkers, Validation Biomarkers), Disease (Cancer, Cardiovascular Disorders, Neurological Disorders, Immunological Disorders, Renal Disorders, and Others), Application (Diagnostics, Drug Discovery and Development, Personalized Medicine, and Others), End User (Pharmaceutical and Biotechnology Companies, Diagnostic and Research Laboratories, Hospitals and Specialty Clinics, and Others), and Region 2024-2032
Purchase options




Benefits of Customization

Personalize this research

Triangulate with your data

Get data as per your format and definition

Gain a deeper dive into a specific application, geography, customer, or competitor

Any level of personalization

Get in Touch With Us
UNITED STATES

Phone: +1-631-791-1145

INDIA

Phone: +91-120-433-0800

UNITED KINGDOM

Phone: +44-753-713-2163

Email: sales@imarcgroup.com

Client Testimonials

Aktive Services

IMARC made the whole process easy. Everyone I spoke with via email was polite, easy to deal with, kept their promises regarding delivery timelines and were solutions focused. From my first contact, I was grateful for the professionalism shown by the whole IMARC team. I recommend IMARC to all that need timely, affordable information and advice. My experience with IMARC was excellent and I can not fault it.

Read More
Greenfish S.A.

The IMARC team was very reactive and flexible with regard to our requests. A very good overall experience. We are happy with the work that IMARC has provided, very complete and detailed. It has contributed to our business needs and provided the market visibility that we required

Read More
Colruyt Group

We were very happy with the collaboration between IMARC and Colruyt. Not only were your prices competitive, IMARC was also pretty fast in understanding the scope and our needs for this project. Even though it was not an easy task, performing a market research during the COVID-19 pandemic, you were able to get us the necessary information we needed. The IMARC team was very easy to work with and they showed us that it would go the extra mile if we needed anything extra

Read More
KRISHAK BHARTI CO-OP LTD

Last project executed by your team was as per our expectations. We also would like to associate for more assignments this year. Kudos to your team.

Read More
Zee Media Corp. Ltd.

We would be happy to reach out to IMARC again, if we need Market Research/Consulting/Consumer Research or any associated service. Overall experience was good, and the data points were quite helpful.

Read More
Arabian Plastic Manufacturing Company Ltd.

The figures of market study were very close to our assumed figures. The presentation of the study was neat and easy to analyse. The requested details of the study were fulfilled. My overall experience with the IMARC Team was satisfactory.

Read More
Sumitomo Corporation

The overall cost of the services were within our expectations. I was happy to have good communications in a timely manner. It was a great and quick way to have the information I needed.

Read More
Hameln Rds

My questions and concerns were answered in a satisfied way. The costs of the services were within our expectations. My overall experience with the IMARC Team was very good.

Read More
Quality Consultants BV

I agree the report was timely delivered, meeting the key objectives of the engagement. We had some discussion on the contents, adjustments were made fast and accurate. The response time was minimum in each case. Very good. You have a satisfied customer.

Read More
TATA Advanced Systems Limited

We would be happy to reach out to IMARC for more market reports in the future. The response from the account sales manager was very good. I appreciate the timely follow ups and post purchase support from the team. My overall experience with IMARC was good.

Read More
Stax

IMARC was a good solution for the data points that we really needed and couldn't find elsewhere. The team was easy to work, quick to respond, and flexible to our customization requests.

Read More